Articles
This Stream includes all of our Articles Flipbooks
-
Read FlipbookWhat Sponsors Want from Sites
-
Read FlipbookWhat Sites Need from Sponsors to be a Top Enroller
-
Request a Genetics in Clinical Trials training session
What You'll Learn -
Read FlipbookInsights for Sites – A Patient’s Perspective
-
Read FlipbookDriving High Performance - Shortening study start-up and optimizing revenue generation
-
Read FlipbookDoes Your Site Measure Up
-
Read FlipbookBe the Site of Choice - Welcome
-
Benchmark your study enrollment versus competitors
Get Benchmark Data -
Read FlipbookAttitude Adjustment - Accelerating for Success Instead of Braking for Failure
-
Read Flipbook2019 CW Global Site Relationship Survey
-
Read FlipbookEnrollment Assistant Site Support
-
Read FlipbookWCG ThreeWire Site Support Solutions
-
Read FlipbookThree Key Performance Metrics for Independent Sites
-
Read FlipbookPlacebo Response Reduction
WCG has developed and validated the industry-leading Placebo Response Reduction training program.
-
Read FlipbookAssessing Cardiac Safety in Oncology Drug Development
This publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks.
-
Read FlipbookLack of Training Compromises Trial Results, Expert Says
At its very core, a clinical trial is a measurement system; yet, the industry has not focused enough on training for everyone involved, from investigators all the way down to the patient.
-
Read FlipbookQ&A: The Role of Expert Committees and the Regulatory Landscape
Dr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared his insights on expert committees during a recent conversation with Bill Stedman.
-
Read FlipbookQ&A with Dr. Nathaniel Katz
Dr. Katz, Chief Science Officer and the founder of Analgesic Solutions, shared his insights during a recent conversation with Mark Opler, MD, PhD, Chief Research Officer at WCG’s MedAvante-ProPhase.
-
Read FlipbookOptimizing SUSAR distribution in a connected– but unharmonized–world
Steven Beales and Joe O’Rourke, vice president, business development talk through some of the difficulties Sponsors face when it comes to safety letter distribution, and how to overcome them.
-
Read FlipbookQuality First: Using Data to Inform Site Selection in CNS
WCG MedAvante-ProPhase espouses a rather simple philosophy: minimize variability, generate cleaner data.
-
Read FlipbookDon’t Do It Alone: To De-Risk Your Next Trial, Seek Outside Expertise
Due to evolving practices and increased regulatory attention on expert committee operations, sponsors are turning more to independent providers with experience in managing expert committees.
-
Read FlipbookProtecting Sponsors Against Bias and Variability
Applied Clinical Trials recently spoke with Mark Opler, PhD, MPH, chief research officer of WCG, MedAvante-ProPhase, to learn why placebo response is the leading cause of failed trials.
-
Loading More...
